Literature DB >> 29793356

Ongoing pregnancies in patients with unexplained recurrent pregnancy loss: adverse obstetric outcomes.

Mauro Cozzolino1,2, Francesca Rizzello2, Chiara Riviello2, Chiara Romanelli2, Maria Coccia Elisabetta2.   

Abstract

To investigate the incidence of adverse pregnancy outcomes in couples with an unexplained Recurrent Pregnancy Loss (RPL) history, a retrospective cohort study was conducted between 2014 and 2015. The study group (A) included couples with an unexplained RPL, and the control group (B) was composed of couples who attended the Low-Risk Antenatal Unit during the same period. On the other hand, 53 couples were included in the study group (A) and on the other hand, 65 in the control group (B). Women with previous unexplained recurrent pregnancies loss had a significantly increased risk of gestational diabetes with 12 cases (22.6%) in the study group and 3 cases (4.6%) in the control (OR: 6.048; 95% CI: 1.607-22.762; p = 0.007). A slight increase in the risk of preterm delivery and hepatic cholestasis was observed in the study group (6 cases, 11.3%, in study group and 1 case, 1.5% in the controls (OR: 8.170; 95% CI: 0.951-70.158; p = 0.0555). Women with a history of RPL delivered more frequently by caesarean section (OR: 3.252; 95% CI: 1.460-7.241; p = 0.0039). Women with a history of RPL were at an increased risk for adverse pregnancy outcomes, mainly gestational diabetes. Therefore, a closer surveillance during the antenatal period is recommended in this group of patients.

Entities:  

Keywords:  Gestational diabetes; hepatic cholestasis; preeclampsia; preterm birth; recurrent pregnancy loss

Mesh:

Year:  2018        PMID: 29793356     DOI: 10.1080/14647273.2018.1475754

Source DB:  PubMed          Journal:  Hum Fertil (Camb)        ISSN: 1464-7273            Impact factor:   2.767


  2 in total

1.  Long Noncoding RNA RP11-115N4.1 Promotes Inflammatory Responses by Interacting With HNRNPH3 and Enhancing the Transcription of HSP70 in Unexplained Recurrent Spontaneous Abortion.

Authors:  Meilan Liu; Xiaoyue Sun; Liqiong Zhu; Menglan Zhu; Kewen Deng; Xiaolu Nie; Hanjie Mo; Tao Du; Bingqian Huang; Lihao Hu; Liuhong Liang; Dongyan Wang; Yinger Luo; Jinling Yi; Jianping Zhang; Xingming Zhong; Chunwei Cao; Hui Chen
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

2.  MAX deficiency impairs human endometrial decidualization through down-regulating OSR2 in women with recurrent spontaneous abortion.

Authors:  Weixu Ma; Mingzhu Cao; Shilei Bi; Lili Du; Jingsi Chen; Haibin Wang; Yufei Jiang; Yixuan Wu; Yixin Liao; Shuangbo Kong; Jianqiao Liu
Journal:  Cell Tissue Res       Date:  2022-02-11       Impact factor: 4.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.